• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白变异性作为腹膜透析患者预后指标的作用:一项回顾性描述性研究。

The role of hemoglobin variability as a prognostic indicator in peritoneal dialysis patients: a retrospective descriptive study.

机构信息

Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Road, 200127, Shanghai, China.

出版信息

Int Urol Nephrol. 2018 Jan;50(1):167-171. doi: 10.1007/s11255-017-1722-8. Epub 2017 Nov 1.

DOI:10.1007/s11255-017-1722-8
PMID:29094332
Abstract

PURPOSE

To investigate the effect of hemoglobin fluctuations on cardiovascular prognosis of patients on peritoneal dialysis (PD).

METHODS

Retrospective descriptive study, with sample composed of 333 patients treated with PD at the Renal Unit. Two indicators were adopted to indicate hemoglobin fluctuations of PD patients: absolute value of hemoglobin variability (HV) and HV trend. Moreover, the new cardiovascular events and recurrent rate of cardiovascular events within 3 months after PD were recorded and were compared in groups of PD patients classified by hemoglobin fluctuation indicators.

RESULTS

Patients whose HV value is less than 10 g/l have an increased risk of new cardiovascular events than patients with HV value > 10 g/l (27.2 vs. 12.2%, p < 0.05) during 3 months after PD. Patients who kept high hemoglobin values (≥ 110 g/l) 3 months after PD are prone to develop recurrent cardiovascular events than patients with relatively low hemoglobin values (< 110 g/l; p < 0.05).

CONCLUSIONS

Hemoglobin fluctuations were associated with the cardiovascular prognosis in patients on PD. A limitation of our study is its retrospective design. However, the results in this research indicated anemia in PD patients without cardiovascular events history should be timely treated. Instead, hemoglobin should be kept within a relatively low level in patients with history of cardiovascular events. Additional clinical researches are needed to verify and improve our findings.

摘要

目的

探讨血红蛋白波动对腹膜透析(PD)患者心血管预后的影响。

方法

回顾性描述性研究,样本由在肾脏科接受 PD 治疗的 333 名患者组成。采用血红蛋白波动的绝对值(HV)和 HV 趋势两个指标来表示 PD 患者的血红蛋白波动情况。此外,记录 PD 患者在 PD 后 3 个月内的新心血管事件和心血管事件复发率,并根据血红蛋白波动指标对患者进行分组比较。

结果

PD 后 3 个月,HV 值<10 g/l 的患者发生新心血管事件的风险高于 HV 值>10 g/l 的患者(27.2%比 12.2%,p<0.05)。PD 后 3 个月保持较高血红蛋白值(≥110 g/l)的患者比血红蛋白值相对较低(<110 g/l)的患者更容易发生复发性心血管事件(p<0.05)。

结论

血红蛋白波动与 PD 患者的心血管预后有关。本研究的局限性在于其回顾性设计。然而,这项研究的结果表明,没有心血管事件史的 PD 患者的贫血应及时治疗。相反,有心血管事件史的患者应将血红蛋白保持在相对较低的水平。需要进一步的临床研究来验证和改进我们的发现。

相似文献

1
The role of hemoglobin variability as a prognostic indicator in peritoneal dialysis patients: a retrospective descriptive study.血红蛋白变异性作为腹膜透析患者预后指标的作用:一项回顾性描述性研究。
Int Urol Nephrol. 2018 Jan;50(1):167-171. doi: 10.1007/s11255-017-1722-8. Epub 2017 Nov 1.
2
High hemoglobin fluctuation was a protective factor for cardiovascular-related death in peritoneal dialysis (PD) patients: A retrospective analysis of 232 patients with PD.高血红蛋白波动是腹膜透析(PD)患者心血管相关死亡的保护因素:对 232 例 PD 患者的回顾性分析。
J Clin Lab Anal. 2022 Jul;36(7):e24548. doi: 10.1002/jcla.24548. Epub 2022 Jun 12.
3
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析患者的透析方式与心血管死亡率比较
Adv Perit Dial. 2016;32:22-31.
4
Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.骨保护素水平升高与腹膜透析患者的炎症、营养不良和新发心血管事件有关。
Atherosclerosis. 2011 Dec;219(2):925-30. doi: 10.1016/j.atherosclerosis.2011.09.025. Epub 2011 Sep 21.
5
Hemoglobin variability does not predict mortality in peritoneal dialysis patients.血红蛋白变异性不能预测腹膜透析患者的死亡率。
Chang Gung Med J. 2012 Jan-Feb;35(1):79-87. doi: 10.4103/2319-4170.106163.
6
Prognostic Value of Predialysis Indices for Technique Failure and Mortality in Peritoneal Dialysis Patients.透析前指标对腹膜透析患者技术失败和死亡率的预后价值
Ther Apher Dial. 2017 Oct;21(5):493-499. doi: 10.1111/1744-9987.12546. Epub 2017 May 15.
7
Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.醛固酮拮抗剂治疗及其与腹膜透析(PD)患者炎症、纤维化、血栓形成、矿物质-骨代谢紊乱和心血管并发症的关系。
Int Urol Nephrol. 2017 Oct;49(10):1867-1873. doi: 10.1007/s11255-017-1655-2. Epub 2017 Jul 14.
8
Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.缺血修饰白蛋白,是持续性不卧床腹膜透析患者主要不良心血管事件的预测标志物。
Clin Biochem. 2013 Oct;46(15):1410-3. doi: 10.1016/j.clinbiochem.2013.06.013. Epub 2013 Jun 21.
9
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.2008年日本透析治疗学会:慢性肾脏病肾性贫血指南
Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.
10
Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients.糖化血红蛋白水平与非糖尿病腹膜透析患者的心血管事件相关。
J Nephrol. 2012 Jan-Feb;25(1):107-12. doi: 10.5301/JN.2011.8350.

引用本文的文献

1
Investigation of Factors Affecting Clinical Outcome of Peritoneal Dialysis Patients.影响腹膜透析患者临床结局的因素调查
Med J Islam Repub Iran. 2024 Mar 27;38:34. doi: 10.47176/mjiri.38.34. eCollection 2024.
2
High hemoglobin fluctuation was a protective factor for cardiovascular-related death in peritoneal dialysis (PD) patients: A retrospective analysis of 232 patients with PD.高血红蛋白波动是腹膜透析(PD)患者心血管相关死亡的保护因素:对 232 例 PD 患者的回顾性分析。
J Clin Lab Anal. 2022 Jul;36(7):e24548. doi: 10.1002/jcla.24548. Epub 2022 Jun 12.
3
Prevalence, associated factors and cardiocerebral vascular prognosis of anaemia among patients on chronic haemodialysis in South Guangdong, China.

本文引用的文献

1
Safety concerns about intravenous iron therapy in patients with chronic kidney disease.慢性肾脏病患者静脉铁剂治疗的安全性问题。
Clin Kidney J. 2016 Apr;9(2):260-7. doi: 10.1093/ckj/sfv142. Epub 2016 Jan 6.
2
Determinants of hemoglobin variability in stable peritoneal dialysis patients.稳定腹膜透析患者血红蛋白变异性的决定因素
Int Urol Nephrol. 2014 Jul;46(7):1427-34. doi: 10.1007/s11255-014-0700-7. Epub 2014 Apr 1.
3
US Renal Data System 2013 Annual Data Report.美国肾脏数据系统2013年度数据报告。
中国粤南地区慢性血液透析患者贫血的患病率、相关因素及心脑血管预后。
J Int Med Res. 2020 Nov;48(11):300060520965791. doi: 10.1177/0300060520965791.
Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001.
4
Effect of hemoglobin variability on mortality and some cardiovascular parameters in hemodialysis patients.血红蛋白变异性对血液透析患者死亡率和某些心血管参数的影响。
Ren Fail. 2013 Jul;35(6):819-24. doi: 10.3109/0886022X.2013.801270.
5
Hemoglobin variability and mortality: confounding by disease severity.血红蛋白变异性与死亡率:疾病严重程度的混杂因素。
Am J Kidney Dis. 2011 Feb;57(2):255-65. doi: 10.1053/j.ajkd.2010.06.013.
6
Hemoglobin variability in anemia of chronic kidney disease.慢性肾脏病贫血中的血红蛋白变异性
J Am Soc Nephrol. 2009 Mar;20(3):479-87. doi: 10.1681/ASN.2007070728. Epub 2009 Feb 11.
7
Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population.美国医疗保险血液透析人群中血红蛋白变异性特征描述方法的比较
Nephrol Dial Transplant. 2009 May;24(5):1378-83. doi: 10.1093/ndt/gfp018. Epub 2009 Feb 5.
8
Hemoglobin level variability: associations with mortality.血红蛋白水平变异性:与死亡率的关联。
Clin J Am Soc Nephrol. 2008 Jan;3(1):133-8. doi: 10.2215/CJN.01610407. Epub 2007 Nov 28.
9
Hemoglobin variability and mortality in ESRD.终末期肾病患者血红蛋白变异性与死亡率
J Am Soc Nephrol. 2007 Dec;18(12):3164-70. doi: 10.1681/ASN.2007010058. Epub 2007 Nov 14.
10
Hemoglobin variability in epoetin-treated hemodialysis patients.促红细胞生成素治疗的血液透析患者的血红蛋白变异性
Kidney Int. 2003 Oct;64(4):1514-21. doi: 10.1046/j.1523-1755.2003.00229.x.